M&T Bank’s AMAG Pharmaceuticals AMAG Stock Holding History

M&T Bank’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,914	Closed	-$202K	–	2087
2015 Q2	$202K	Buy	+2,914	New	+$183K	﹤0.01%	1779

Other funds holding AMAG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

M&T Bank's AMAG Position: Q3 2015 in Review

M&T Bank sold out of AMAG Pharmaceuticals (AMAG) in Q3 2015, closing a stake of 2,914 shares — an estimated $202K sold.

M&T Bank first reported a position in AMAG in Q2 2015 and held it in 1 quarter. The position peaked at $202K in Q2 2015. 210 funds tracked by Wall St. Rank hold AMAG as of Q3 2015.

M&T Bank reported no remaining AMAG Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
M&T Bank sold 2,914 AMAG Pharmaceuticals shares in Q3 2015, an estimated $202K.
M&T Bank first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 1 quarter.
M&T Bank's AMAG Pharmaceuticals position peaked at $202K in Q2 2015.
210 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.